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We have demonstrated that 1-deoxynojirimycin (DNJ)
isolated from Bacillus subtilis MORI could enhance the
levels of adiponectin and its receptors in differentiated
3T3-L1 adipocytes, which has been shown to be effective
in lowering blood glucose levels and enhancing insulin
sensitivity. DNJ was not toxic to differentiated 3T3-L1
adipocytes for up to a concentration of 5 µM. In terms of
expression levels of adiponectin and its receptors (AdipoR1
and AdipoR2), DNJ in concentrations as low as 0.5 µM
elevated both mRNA and protein levels of adiponectin and
transcript levels of AdipoR1 and AdipoR2. In addition, DNJ
increased phosphorylation of 5' adenosine monophosphate-
activated protein kinase (AMPK) in a statistically significant
manner. Finally, treatment with DNJ resulted in increased
mRNA expression of glucose transporter 4 (GLUT4), which
encodes for a glucose transporter, along with a significant
increase in glucose uptake into the adipocytes based on
results of a 2-deoxy-D-[
3
H] glucose uptake assay. Our
findings indicate that DNJ may greatly facilitate glucose
uptake into adipose tissues by increasing the action of
adiponectin via its up-regulated expression as well as its
receptor genes. In addition, the glucose-lowering effects of
DNJ may be achieved by an increased abundance of
GLUT4 protein in the plasma membrane, as a consequence
of the increased transcript levels of the GLUT4 gene and
the activation of AMPK.
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An increasing body of evidence suggests that adipose
tissues play a crucial role in maintaining glucose and fat
homeostasis not only by acting as a major organ to store
excess energy but also by secreting adipokines including
adiponectin [21]. Adiponectin receives great attention
because of its strong association with visceral adipocytes
and insulin resistance [9]. Interestingly, obesity and body
mass index (BMI), an indicator of obesity, have been
shown to be inversely correlated to serum adiponectin
levels [2, 3]. Furthermore, low levels of serum adiponectin
concentrations are reported to increase the risk of insulin
resistance, cardiovascular disease, and inflammatory conditions
[16, 32]. Since insulin resistance is a well known contributor
to the development of metabolic disorders, including type-2
diabetes and cardiovascular diseases, proper maintenance
of insulin sensitivity is crucial for the prevention or
amelioration of such disorders [19]. Adiponectin exerts
its biological actions via interacting with two types of
adiponectin receptors, AdipoR1 and AdipoR2 [8]. AdipoR1
has a greater affinity for the globular form than the full-
length form of adiponectin and is abundantly enriched in
endothelial cells and skeletal muscle [5]. AdipoR2 exhibits
moderate affinity for either forms of adiponectin and is
highly detected in the liver [5]. AdipoR1 and AdipoR2 are
found both in the preadipocytes and adipocytes [1].
1-Deoxynojirimycin (DNJ) is known to ameliorate diabetic
conditions by improving insulin sensitivity [13], exerting
its effect partially through inhibiting the activity of α-
glucosidase and the absorption levels of glucose in the
intestinal brush border [14]. Additionally, the iminosugar
N-(5-adamantane-1-yl-methoxy-pentyl)-deoxynojirimycin
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(AMP-DNJ) was also shown to improve insulin sensitivity,
adipocyte function, and hepatic steatosis by its effect on
glycosphingolipid levels [8, 25]. However, the effects of
DNJ on metabolically active adipocytes remain largely
unknown. In fact, only one study has reported that animals
fed with DNJ demonstrated increased adiponectin mRNA
levels in their adipose tissue [24]. Since the first isolation
of DNJ from mulberry (Morus alba), known as a primary
food source for silkworms [27], studies on glucose and
lipid metabolism have been conducted with this compound
produced from the root and leaf of mulberry trees [3, 12, 25].
On the other hand, some limited groups of microorganisms,
such as Bacilli and Streptomyces, are also known to produce
DNJ [4, 6, 7, 10].
In the current study, we examined direct effects of DNJ
isolated from Bacillus subtilis MORI on cultured 3T3-L1
adipocytes and explored the possible regulatory mechanisms
to enhance insulin sensitivity by DNJ treatment. Considering
the crucial role that adiponectin plays in improving insulin
sensitivity, we hypothesized that DNJ improves the
dysregulated metabolic conditions by enhancing the production
of and circulating levels of adiponectin as well as up-
regulating the glucose transport protein GLUT4.
MATERIALS AND METHODS
Cell Culture and Adipocyte Differentiation 
Mouse 3T3-L1 cells were grown in high-glucose Dulbecco’s minimum
essential medium (DMEM) supplemented with 10% heat-inactivated
bovine calf serum (BCS) containing 100,000 units/l penicillin and
100 mg/l streptomycin. Prior to the experiments, 1×105 cells were
seeded on a 6-well plate and grown to confluence for 7 days. At day
8 post-confluence, the cells were subjected to the first differentiation
medium (DMEM, 10% FBS, 0.5 mM 3-isobutyl-1-methylxanthine,
0.5 µM dexamethasone, 2 µg/ml insulin) starting on day 0, for 3 days.
Then the medium was replaced with the second differentiation
medium (DMEM, 10% FBS, 1 µg/ml insulin). Two days later, the
cells were grown in regular medium (DMEM, 10% FBS) for an
additional 2 days. The cells were maintained at 37
o
C in a humidified
atmosphere of 95% air and 5% CO2. The growth medium was
replenished every 2 days. Isobutyl-1-methylxanthine, dexamethasone,
and insulin were obtained from Sigma-Aldrich (St. Louis, USA).
3T3-L1 cells were obtained from the American Type Culture
Collection (ATCC, USA). Other cell culture materials were purchased
from Gibco-Invitrogen (USA). In this study, cells were exposed to
medium with DNJ concentrations varying from 0.5 to 5 µM.
MTT Assay 
DNJ isolated from Bacillus subtilis MORI [10] was prepared in a
DMSO solution at a concentration of 1 mg/ml. Fully differentiated
3T3-L1 cells were tested with increasing concentrations of DNJ
(final concentrations of 0.5, 2.5, and 5 µM) for 24 h. Cell viability
was analyzed after the addition of 1 mg/ml MTT in each well and
an another additional incubation for 3 h at 37
o
C. After removal of the
medium, cells were lysed with DMSO. The absorbance was detected
at the 560 nm wavelength using a microplate reader.
Immunoblot Analysis 
The cells were scraped from the plates with lysis buffer (40 mM
HEPES, pH 7.5, 120 mM NaCl, 1 mM EDTA, 1% Triton X-100)
containing a protease inhibitor cocktail (Roche, Germany). After
incubation on ice for 20 min, cell lysates were centrifuged at 12,000 ×g
for 15 min at 4
o
C. Total protein in the cell supernatants was quantified
using the BCA protein assay (Sigma-Aldrich, USA). Protein lysates
were resolved on 10% sodium-dodecyl sulfate polyacrylamide gels
(SDS-PAGE) and then transferred to a polyvinylidene difluoride
(PVDF) membrane. Anti-adiponectin, anti-AMPK, and anti-phospho-
AMPK antibodies (Cell Signaling, USA) were used to detect
adiponectin, AMPK, and the phosphorylated form of AMPK,
respectively. The medium was taken from 3T3-L1 adipocytes
treated with DNJ for 24 h and subjected to SDS-PAGE, and anti-
adiponectin antibody was used to detect adiponectin.
RNA Extraction and Semiquantitative RT-PCR 
Total RNA was extracted from differentiated 3T3-L1 cells using an
RNeasy Lipid Tissue Mini Kit (Qiagen, Germany) according to the
manufacturer’s protocol. The cDNA was synthesized from 1 µg of
RNA using oligo-dT and Superscript II reverse transcriptase
(Invitrogen, Carlsbad, CA, USA). Primer sequences for PCR are the
following: adiponectin, 5'-GTTGCAAGCTCTCCTGTTCC-3' (forward)
and 5'-GCTTCTCCAGGCTCTCCTTT-3' (reverse); adiponectin
receptor 1, 5'-TCTCCTGGCTCTTCCACACT-3' (forward) and 5'-
GACAAAGCCCTCAGCGATAG-3' (reverse); adiponectin receptor
2, 5'-ACCCACAACCTTGCTTCATC-3' (forward) and 5'-TAGCCA
GCCTATCTGCCCTA-3' (reverse); GLUT4, 5'-CAACAGCTCTCA
GGCATCAA-3' (forward) and 5'-CTCAAAGAAGGCCACAAAGC-
3' (reverse); GAPDH, 5'-AACTTTGGCATTGTGGAAGG-3' (forward)
and 5'-ACACATTGGGGGTAGGAACA-3' (reverse). The PCR products
were then separated by electrophoresis on a 2% agarose gel. The
separated bands were visualized using a UV transilluminator. The
images were captured using a Sigma EXDG camera (Nikon, Tokyo,
Japan). The intensity of the bands was quantitated using the Alphaview
software (Alpha Innotech, USA). Values were expressed in arbitrary
units. The mRNA levels were determined by relative values to that
of an endogenous GAPDH gene and expressed as fold change over
the control.
Glucose Uptake Assay
As previously described [30], glucose uptake into adipocytes was
measured using a 2-deoxy-D-[3H] glucose (PerkinElmer, USA). Fully
differentiated 3T3-L1 cells were treated with 0.5 µM of DNJ for
24 h. After being washed with PBS, the cells were then incubated in
1 ml of PBS containing 1 µCi/ml 2-deoxy-D-[
3
H] glucose and 0.1 mM
2-deoxy-D-glucose for 10 min. The cells were washed in cold PBS
and lysed with 1% SDS in PBS. The 3H-glucose content was detected
in 8 ml of scintillation cocktail using a liquid scintillation counter
(Beckman Coulter, USA).
Statistical Analysis
Statistical analysis was performed using the SPSS (Statistical Package
for the Social Science, SPSS Inc., USA). The results were presented
as the mean ± SE, and the differences among the experimental groups
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were analyzed using a Student t-test at p < 0.05 as the criterion of
significance.
RESULTS 
Up-Regulated Expression of Adiponectin upon DNJ
Treatment 
In order to determine any toxic effects of DNJ treatment on
differentiated 3T3-L1 cells, we performed the MTT assay
and found out that DNJ did not adversely affect cell
viability at concentrations up to 5 µM (Fig. 1A). Using
the same range of concentrations, we examined the effects
of DNJ on adiponectin gene expression. DNJ treatment
significantly increased the transcript levels of the adiponectin
gene (Fig. 1B). DNJ at 0.5 µM was sufficient to elicit up-
regulation of the adiponectin gene. These changes in
mRNA levels were accompanied by an increase in protein
levels of adiponectin (Fig. 1C). Treatment of 5 µM of DNJ
led to a 2-fold increase in the adiponectin protein amount
in comparison with the control without DNJ (Fig. 1C). The
extent of DNJ-induced increase in protein levels was
Fig. 1. Effect of DNJ on the expression of adiponectin gene and adiponectin secretion in 3T3-L1 adipocytes.
(A) 3T3-L1 cells were differentiated into adipocytes according to the differentiation protocol. Cell viability was analyzed using an MTT assay after
treatment with DNJ for 24 h. (B) Differentiated 3T3-L1 cells were treated with DNJ for 24 h. Semiquantitative RT-PCR was performed to detect the levels
of adiponectin in the cells. (C) Differentiated 3T3-L1 cells were treated with DNJ for 24 h. Immunoblot analysis was performed with anti-adiponectin
antibody. A representative blot is shown in the upper panel. The bar graph represents quantification of the relative protein levels of adiponectin. (D) The
culture medium of 3T3-L1 cells treated with DNJ for 24 h subjected to immunoblot analysis. A representative blot is shown in the upper panel. The bar
graph represents quantification of the level of secreted adiponectin. The results were expressed as the mean ± SE of at least five independent experimental
results. p < 0.05 by the Student t-test.
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positively associated with the concentrations of DNJ,
indicating that there is a dose-dependent effect of DNJ on
the increase of adiponectin proteins. We also investigated
whether DNJ could increase the secretion of adiponectin.
Adiponectin secretion into the medium greatly increased
upon treatment with 0.5 µM of DNJ (Fig. 1D). However,
there were no further effects of DNJ with concentrations
higher than 0.5 µM on the adiponectin secretion (Fig. 1D).
Our data demonstrated that DNJ effectively up-regulated
the expression of the adiponectin gene and enhanced
secretion of adiponectin protein into the medium. 
DNJ Increased mRNA Expression of AdipoR1 and
AdipoR2 
We subsequently determined the expression levels of the
AdipoR1 and AdipoR2 genes in differentiated 3T3-L1
adipocytes. There were approximately 2-fold increases in
AdipoR1 and AdipoR2 mRNA levels in the adipocytes
treated with DNJ in a concentration-dependent manner
(Figs. 2A and 2B). These results demonstrated that DNJ
up-regulates AdipoR1 and AdipoR2 gene expression. 
Activation of AMPK by DNJ 
In addition to the effect of DNJ on the expression of
adiponectin and AdipoR1 and AdipoR2, we investigated
whether DNJ influences the activation of AMPK in
differentiated 3T3-L1 adipocytes. AMPK has been implicated
in glucose utilization and in fatty acid oxidation [15]. Since
the activation of adiponectin triggers AMPK signaling [32],
AMPK-mediated activities of adiponectin are suggested to
enhance insulin sensitivity [17]. We added varying amounts
of DNJ to the differentiated 3T3-L1 cells for 24 h. We
observed an increasing trend in the phosphorylated form of
AMPK protein levels upon treatment with DNJ, as low as
0.5 µM (Fig. 3). DNJ significantly raised the levels of
phosphorylated AMPK. This demonstrates that DNJ
phosphorylates and activates AMPK in 3T3-L1 adipocytes.
Fig. 2. Effect of DNJ on the expression of AdipoR1 and AdipoR2 in 3T3-L1 adipocytes. 
Differentiated 3T3-L1 cells were treated with DNJ for 24 h. Total RNA was purified from cells and subjected to RT-PCR analyses using primers specific for
AdipoR1 (A) and AdipoR2 (B). The results were expressed as the mean ± SE of at least five independent experimental results. p < 0.05 by the Student t-test.
Fig. 3. Effect of DNJ on phosphorylation of AMPK in 3T3-L1
adipocytes. 
Differentiated 3T3-L1 cells were treated with DNJ for 24 h. Cell lysates
were subjected to immunoblot analysis using anti-phospho-AMPK antibody.
A representative blot is shown in the upper panel. The levels of phospho-
AMPK were normalized to total AMPK for each sample in the graph on
the lower panel. The results were expressed as the mean ± SE of at least
five independent experimental results. p < 0.05 by the Student t-test.
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DNJ Enhanced GLUT4 Transcript Levels and Glucose
Uptake into Adipocytes 
We also observed the changes in GLUT4 transcript levels
after 24 h incubation with DNJ in fully differentiated 3T3-
L1 adipocytes. DNJ treatment of 0.5 µM induced a 1.8-
fold increase in GLUT4 mRNA levels (Fig. 4A). Because
0.5 µM of DNJ was the lowest effective concentration to
induce expressions of GLUT4, adiponectin, and adipoR1
and R2, we chose to use this concentration to investigate
whether fully differentiated adipocytes increase glucose
uptake in response to DNJ. Upon the addition of 0.5 µM of
DNJ, an approximately 2.1-fold induction of glucose
uptake was observed in adipocytes compared with that of
DMSO-treated cells (Fig. 4B). These results demonstrated
that DNJ indeed was effective in increasing the expression
of GLUT4 as well as glucose uptake into adipocytes with
as low as 0.5 µM concentration.
DISCUSSION 
There has been increasing efforts in developing ways to
increase systemic insulin sensitivity using dietary components
from natural products. In this study, we showed that DNJ
isolated from Bacillus subtilis MORI increased the mRNA
and protein levels of the adiponectin gene in 3T3-L1
adipocytes. It was previously reported that circulating
adiponectin levels was positively associated with insulin
sensitivity. In addition, a positive correlation between
adiponectin levels in 3T3-L1 adipocytes and insulin
sensitivity was reported in a study using a PPARγ agonist,
a drug that improves insulin sensitivity [28]. Therefore, our
findings suggest that DNJ may greatly enhance adiponectin
signaling in adipocytes by increasing the amounts of serum
adiponectin. The positive effect of DNJ in elevating
adiponectin levels had been previously demonstrated in a
study in which a DNJ-containing mulberry leaf extract up-
regulated adiponectin gene expression [22].
We also demonstrated that DNJ increased transcript
levels of adiponectin receptor genes. Insulin has been shown
to modulate AdipoR gene expression [23]. As the blood
insulin levels fluctuated depending on the fed/fasting
states, AdipoR expression also changed accordingly [23].
AdipoR levels decreased as insulin levels were elevated.
AdipoR may play a crucial role in glucose uptake into the
tissues when the insulin level is low. Therefore, it appears
that regulation of AdipoR gene expression may be an
additional exerting effect of insulin on target tissues. In
addition, a marked decrease in AdipoR mRNA levels was
reported in an obese mouse model with insulin resistance
[23], which suggested that adequate amounts of AdipoR
gene expression may help maintain insulin sensitivity. The
types of AdipoR expressed in different tissues may affect
the function of adiponectin in those tissues. For instance,
adiponectin receptors are suggested to play a role in insulin
secretion in pancreatic β cells [11]. In our study, we
suggest that AdipoR expression in 3T3-L1 adipocytes
increases insulin sensitivity in response to DNJ. Wu X et
al. [26] reported that adiponectin increased glucose uptake
into primary rat adipocytes via AMPK activation, without
Fig. 4. Effect of DNJ on the mRNA level of the GLUT4 gene and on glucose uptake in 3T3-L1 adipocytes. 
(A) Differentiated 3T3-L1 cells were treated with DNJ for 24 h and then harvested for RNA extraction. GLUT4 mRNA levels were measured using semi-
quantitative RT-PCR. The results were expressed as the mean ± SE of at least five independent experimental results. p < 0.05 by the Student t-test. (B)
Differentiated 3T3-L1 cells were treated with 0.5 µM of DNJ for 24 h. After being washed with PBS, the cells were then incubated with 1 µCi/ml 2-deoxy-
D-[
3
H] glucose and 0.1 mM 2-deoxy-D-glucose for 10 min. The cells were washed in PBS and lysed with 1% SDS in PBS. The glucose uptake was
determined by the measurement of 
3
H-glucose content using a liquid scintillation counter. Relative fold of glucose uptake is shown in the graph. The results
were expressed as the mean ± SE of at least five independent experimental results. p < 0.05 by the Student t-test.
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demonstrating the levels of AdipoR gene expression. In
our study, we demonstrated that DNJ enhances mRNA
expressions of AdipoR1 and AdipoR2 as well as adiponectin
protein production in differentiated 3T3-L1 adipocytes.
Therefore, we speculate that DNJ may further enhance
adiponectin activities by increasing the plasma membrane
expressions of AdipoR1 and AdipoR2 in order to enhance
adiponectin effects, such as glucose uptake into adipocytes.
Adiponectin has been shown to stimulate glucose
uptake in adipocytes [26]. Isolated fat cells increased
glucose uptake in response to mulberry leaf extracts [22].
The mulberry leaf extract lowered the blood glucose content
in a diabetic mouse model induced by streptozotocin [22].
Usually, insulin is a main factor that stimulates the
translocation of GLUT4 to the plasma membrane to
mediate glucose transport. However, AMPK activation in
skeletal muscle cells can also induce the translocation of
GLUT4 protein to the plasma membrane, which is insulin-
independent [18]. The insulin-sensitizing effect of adiponectin
was previously shown to be mediated by the activation of
AMPK [29]. In our study, DNJ-mediated activation of
AMPK in 3T3-L1 adipocytes was detected by a significant
increase in phosphorylation of AMPK. Therefore, it is
likely that DNJ can exert glucose-lowering effects through
the activation of the AMPK pathway and translocation of
the GLUT4 gene. In skeletal muscle cells, activation of
AMPK by AICAR, an activator of AMP kinase, was able
to drive GLUT4 transcription [31]. Therefore, it is possible
that DNJ-mediated activation of AMPK triggers GLUT4
transcription in addition to its translocation to the plasma
membrane. An increase in the production of GLUT4 by
DNJ can lead to an increase in GLUT4 protein levels in the
plasma membrane for glucose uptake upon the right
stimuli. Although we did not determine whether direct
DNJ treatment increased the expression of GLUT4 at the
plasma membrane in 3T3-L1 adipocytes, DNJ-containing
mulberry leaf extracts have been shown to enhance
GLUT4 translocation in adipocytes [20]. DNJ may play an
essential role in lowering blood glucose levels by increasing
GLUT4 protein expression translocated to the plasma
membrane, steps that may involve AMPK activation. In
our assay using 2-deoxy-D-[3H] glucose in DNJ-treated
adipocytes, we noticed a significant increase in glucose
uptake into the cells. Our results are consistent with a
recent report showing that mulberry leaf extract containing
DNJ enhanced glucose uptake to adipocytes [20]. Therefore,
it is likely that an increase in glucose uptake upon
DNJ treatment may be partly attributable to an increased
expression of GLUT4 and phosphorylation of AMPK in
adipocytes.
Taken together, we propose that DNJ can be used as a
dietary supplement and/or therapeutic agent to prevent or
ameliorate insulin resistance, respectively. DNJ can be
used in combination with insulin-sensitizing drugs to
enhance the action of the drug in an insulin-resistant state.
Furthermore, our study can be substantiated by assessing
the glucose-lowering effects of DNJ in vivo in the future.
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